Patent 7268358 was granted and assigned to Fox Chase Cancer Center (company) on September, 2007 by the United States Patent and Trademark Office.
Methods of optimizing a laser-accelerated proton radiation dose to a targeted region are disclosed. Disclosed methods include providing a plurality of modulated polyenergetic proton beamlets and irradiating the targeted region with the plurality of modulated beamlets.